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Abstract
Background
Attentional bias toward sleep-related information is believed to play a key role in insomnia. If
attentional bias is indeed of importance, changing this bias should then in turn have effects
on insomnia complaints. In this double-blind placebo controlled randomized trial we investi-
gated the efficacy of attentional bias modification training in the treatment of insomnia.
Method
We administered baseline, post-test, and one-week follow-up measurements of insomnia
severity, sleep-related worry, depression, and anxiety. Participants meeting DSM-5 criteria
for insomnia were randomized into an attentional bias training group (n = 67) or a placebo
training group (n = 70). Both groups received eight training sessions over the course of two
weeks. All participants kept a sleep diary for four consecutive weeks (one week before until
one week after the training sessions).
Results
There was no additional benefit for the attentional bias training over the placebo training on
sleep-related indices/outcome measures.
Conclusions
The absence of the effect may be explained by the fact that there was neither attentional
bias at baseline nor any reduction in the bias after the training. Either way, this study gives
no support for attentional bias modification training as a stand-alone intervention for amelio-
rating insomnia complaints.
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Introduction
Insomnia is a prevalent disorder that affects about 10% of the general population [1]. In the
DSM-5, chronic insomnia is described as problems with initiating and/or staying asleep for at
least three days a week for three or more months. Furthermore, these sleep problems need to
have a negative effect on daytime functioning [2]. Indeed, people with insomnia report lower
concentration, cognitive problems and emotional instability [3, 4]. Furthermore, insomnia is
associated with psychopathology such as anxiety and depression [5]. For example, insomnia
disorder is associated with a twofold chance of developing a major depression disorder in later
life [6]. Apart from these psychological correlates, insomnia is also associated with somatic
problems such as cardiovascular diseases [7].
Such a prevalent and impairing disorder calls for effective treatments. In general, insomnia
is most effectively treated with Cognitive Behavioral Treatment for Insomnia (CBT-I). People
with insomnia benefit from CBT-I, with meta-analyses reporting large treatment effects on
insomnia severity [8–10]. However, not all people suffering from insomnia benefit from
CBT-I. For instance, Morin and Benca [11] estimate that up to 70–80% of insomniac patients
show a clinically meaningful response to treatment and only about 40% achieve clinical remis-
sion. This shows that even though the treatment is highly effective, further improving its effi-
cacy should be a high priority.
An additional issue with CBT-I interventions is that they tend to be time and resource
intensive for both clinicians and clients. Consequently, the availability of such treatments is
recognized as being low in relation to need. Thus, restricted access to treatment, problems
with patient motivation and adherence, and the real or perceived costs can limit the utility and
uptake of such interventions [12]. While some very positive steps have been taken to increase
the accessibility of CBT-I programs through online delivery [13], CBT-I nevertheless requires
a sustained high level of motivation and engagement on the part of the help-seeking individual,
across an extended period of time, to actively challenge the dysfunctional cognitive distortions
that maintain sleep difficulties, and alter problematic patterns of behaviour.
One possible approach that may hold potential benefits to the treatment of insomnia is
focusing (also) on maladaptive automatic cognitive information processes, such as selectively
attending to sleep-related cues in the environment (i.e., attentional bias). Theoretically, it has
been argued that attentional bias toward sleep-related information is supposed to play a key
role in insomnia. For instance, Harvey’s [14] cognitive model of insomnia proposes that exces-
sive negative cognitive activity leads to cognitive arousal and stress. This leads to selective
attention (and monitoring) for negative threatening sleep-related cues. In her model, the selec-
tive attention results in a distorted perception of the sleep impairment and daytime conse-
quences and fuels the excessive negative cognitive activity. All these factors together may
cumulate into real impairment in sleep and daytime functioning and can turn into insomnia.
In another influential model, Espie and colleagues [15] further elaborate on selective atten-
tion in the context of insomnia in the attention-intention-effort pathway (A-I-E model). In
this model, it is stated that sleep is an automatic process. However, this process is fragile and
can be inhibited by the attention to focus on the sleep and/or directly suppress it. Espie and
colleagues suggest that the sleeping system at first is threatened by selective attention toward
sleep (attention), then it can be compromised by the explicit intention to sleep (intention) and
eventually disrupted by a destructive combination of direct and indirect effort to sleep (effort).
That is why insomnia, in this model, is seen as a ‘sleep-effort syndrome’, which is characterized
by attentional bias, sleep preoccupation and mental and behavioral strategies to sleep and to
avoid insomnia.
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In line with these two models, it has been shown that people with insomnia show an atten-
tional bias towards sleep-related stimuli [16–19]. However, a number of studies did not
observe a sleep-related attentional bias [20–22]. In a meta-analysis, Harris and colleagues [23]
recently concluded that poor sleepers have a medium to large sleep-related attentional bias
compared to controls. Attentional bias thus appears to be associated with insomnia.
A viable next step seems to be testing whether the maladaptive, sleep-related attentional
bias can also be modified with an attentional bias modification training (ABM) and whether
this affects insomnia severity and sleep indices. Over the last years, different ABM training par-
adigms have been developed in the field of anxiety, whereby subjects are trained to shift their
attention from threatening information (usually operationalized with pictures or words)
toward neutral or positive information [24]. At first, very promising results for anxiety were
observed with ABM procedures using the dot-probe task [25]. However, currently, ABM train-
ings for anxiety and depression are subject to more controversy with recent meta-analyses
finding moderate [26] or even clinically not relevant effects [27]. Crucially, while the clinical
effects of ABM have been somewhat inconsistent, the mechanistic link between changes in
attentional bias and consequent changes in emotional vulnerability remains sound, with those
studies failing to achieve changes in attentional bias typically also failing to observe clinical
benefits [24]. Thus, it should be noted that the critical ingredient of an effective ABM training
is modifying the attentional bias. A failure to manipulate the attentional bias should be inter-
preted accordingly and does not in itself provide evidence against the possible therapeutic
value of ABM [28].
To our knowledge, there have been two studies that have sought to examine ABM training
in insomnia to date, both of which have employed experimental designs with sub-clinical sam-
ples [29, 30]. Milkins et al. [30] employed a within-subjects design where 18 individuals report-
ing high levels of insomnia symptoms alternated completing an ABM task and a non-ABM
control task before bed across six consecutive nights. While participants had no awareness of
the change in tasks, they consistently reported shorter sleep onset latencies and lower pre-sleep
worry on nights they had completed the ABM task compared to nights they completed the
control task. In a follow-up between-subjects design, 41 students with sleep problems received
five sessions of ABM or control training across as many nights. The authors showed that par-
ticipants who performed the ABM training reported fewer sleep-related worries at post-test,
compared to the placebo condition. However, no effects were observed for insomnia severity
or sleep-related attentional bias. In addition, ABM training effects were observed on objective
measures of sleep onset latency, but not on onset latency as measured with a subjective diary
[29].
Overall, these studies provide some encouraging initial findings suggesting possible benefits
of ABM for insomnia. As acknowledged by the authors however, a larger scale randomized
controlled trial with a clinical sample is necessary in order to establish the therapeutic potential
of such an intervention. Furthermore, these studies observed no changes in sleep-related atten-
tional bias. This could have been due to a type II error (i.e., not observing an effect on atten-
tional bias that is actually there). However, the absence of a change in attentional bias and the
small sample size also raises the question whether the changes in sleep-related worry and sleep
onset latency resulted from ABM or were due to other processes, including the possibility of
type I errors (i.e., observing an effect that is actually not there). Thus the aim of the current
study was to conceptually replicate these previous findings in a larger sample. Furthermore,
we sought to determine if the effects of ABM training would be demonstrated in people meet-
ing DSM-5 criteria for insomnia opposed to having only ‘sleep problems’ such as in Clarke
et al.’s study.
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Therefore, we set up a double-blind placebo controlled ABM study that differed from the
Clarke study on a number of key aspects. Firstly, we included a sample of people with clinical
levels of insomnia and also recruited a larger sample to ensure the study was adequately pow-
ered. Furthermore, a larger number of total training sessions were delivered over a longer
period of time [31]; as such eight ABM sessions were delivered on as many training days
within a two-week time frame. Lastly, we not only included a post-test but also a one-week fol-
low-up measurement. Our hypotheses were the following: 1. Participants with insomnia will
show an attentional bias towards sleep-related words at baseline. 2. Participants that receive
ABM training will show a greater reduction on attentional bias compared to participants
receiving the placebo training. 3. Participants that receive and ABM training will show a
greater reduction on sleep complaints, sleep-related worry, and anxiety and depression mea-
sures compared to participants receiving the placebo training.
Material and methods
Participants
Volunteers were recruited via a popular scientific Dutch website (www.insomnie.nl). Inclusion
criteria were being at least eighteen years old, meeting DSM-5 criteria for insomnia (APA,
2013) and an Insomnia Severity Index of 10 or higher (Morin, Belleville, Be´langer & Ivers,
2011). Exclusion criteria included starting a psychotherapy in the past six months, alcohol or
drug abuse, high score on depressive symptoms (CES-D score of 27 or higher) [32], self-
reported diagnosis of psychosis/schizophrenia, indication for sleep apnea (score of 16 or
higher on the sleep apnea scale of the SLEEP-50) [33], doing shift-work, pregnancy or breast-
feeding. We sent an invitation e-mail to 1725 people who earlier expressed their interest in
insomnia studies. From these invitations, 257 started with the first online questionnaire. Of
these, 100 were excluded from the study due to ineligibility and another 20 did not fill in suffi-
cient days (6) of the sleep diary. Fig 1 provides a flowchart and numbers of participants
excluded per criterion. This left us with a sample of 137 participants that were randomized
into the ABM-training (n = 67) or ABM-placebo condition (n = 70). Please see Table 1 for
demographics.
Power
We based our power estimation on the meta-analysis of Hakamata and colleagues [25] on
ABM training for anxiety. In this meta-analysis a mean effect size equal to Cohen’s d = .61 was
found. Based on a t-test, a power of .80 and an alpha level of .05 (two-sided) we needed to have
44 participants per condition. However, because we were not fully confident that we could
achieve a Cohen’s d of .61 in insomnia patients and we wanted to correct for potential drop-
out, we aimed to include 25 participants extra per group.
Measurements
Dot-probe task. In order to measure attentional bias towards sleep-related cues, a modi-
fied version of the dot-probe task was used and measured online [34]. The dot-probe task is a
computerized speeded reaction-time task wherein two cues appear simultaneously at different
locations on a computer screen. After the cues disappear, a target probe appears at the location
of one of the two cues. Participants are required to respond as fast as possible to a feature of
the probe. In the version of the task employed in the current study, each trial began with a fixa-
tion cross displayed on the screen for a duration randomly drawn from a uniform distribution
ranging from 500ms to 1000ms. Thereafter, a negative sleep-related word and a neutral word
Attentional bias modification for insomnia
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Fig 1. Flowchart. Note. For the attentional bias measurements there were 57 (active) and 64 (placebo) valid cases for the baseline. There were 39 (active)
and 45 (placebo) valid cases for the post-test.
https://doi.org/10.1371/journal.pone.0174531.g001
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are displayed either on the left or on the right side of the screen for 500 milliseconds (left/right
side is counterbalanced), followed by an arrow (the target probe) pointing upwards or down-
wards displayed at the location of one of the words for 750 milliseconds. The participant is
required to indicate the direction of the arrow by pressing the corresponding button on the
computer keyboard (‘U’ or ‘N’; pairing of arrow direction and response button is counterbal-
anced across participants). The task is composed of a first practice block of four practice trials
and two blocks of 96 test trials each. When participants selectively pay more attention to the
sleep-related words, they will be quicker in responding to the arrow when it appears on the
location of these words in comparison to the neutral words (the attentional bias). To compute
the attentional bias score we subtracted the average response time when the target was pre-
sented at the location of a sleep-related word from the average response time when the target
was presented at the location of a neutral-word. The higher the resulting score, the higher the
attentional bias.
Questionnaires. At baseline, demographics such as gender and age were assessed. Fur-
thermore, task contingency awareness in terms of the relationship between the position of the
arrow probes and the words was measured at post-test.
The primary measure is the Insomnia Severity Index (ISI) [35]. The ISI contains seven
items that measure the severity of insomnia complaints. Items are scored on a 0–4 Likert scale
and the total ranges between 0 and 28, with higher scores indicating more severe insomnia. A
score 10 is used to indicate clinical insomnia [36]. Cronbach’s α is equal to .76, indicating
high internal consistency. The ISI shows good construct validity since it is highly correlated
with the sleep diary and polysomnography [37].
The Pittsburgh Sleep Quality Index (PSQI) measures the quality of sleep [38]. The PSQI is
scored on a scale of seven components: sleep quality, sleep latency, sleep duration, sleep effi-
ciency, sleep disturbances, use of sleeping medication and daytime functioning. Each compo-
nent is rated on a 0–3 Likert scale and the total scale ranges from 0 to 21. Overall the scale has
good internal consistency (α = .83) and a global PSQI score greater than 5 has high sensitivity
(89.6%) and specificity (86.5%) to distinguish between good and poor sleepers [38].
Depression was measured using a Dutch translation of the 20-item Centre of Epidemiologi-
cal Studies Depression scale (CES-D) [39]. The items are scored on a 0–3 Likert scale and the
total ranges from 0 (no depressive symptoms) to 60 (severe depressive symptoms). A score 27
is used to indicate more severe depression symptoms [32]. This scale has good internal
Table 1. Demographic and Clinical Characteristics at Baseline.
Experimental Placebo
Age M (SD) 48.47 (14.76) 47.72 (11.90) t(135) = -0.33; p = .74
n % n %
Gender Female 49 70.0% 51 76.1% χ2 (1) = 0.65; p = 0.45
Prescribed sleep medication Yes 17 24.3% 16 23.9% χ 2 (1) = 0.00; p = 1.00
In psychological treatment Yes 4 5.7% 2 3.0% χ 2 (1) = 0.61; p = 0.68
Living together with partner Yes 52 74.3% 47 70.1% χ 2 (1) = 0.29; p = 0.70
Currently employed Yes 56 80.0% 45 67.2% χ 2 (1) = 2.91; p = 0.12
Insomnia of physical origin Yes 6 8.6% 2 3.0% χ 2 (1) = 1.94; p = 0.28
Years insomnia 1year 8 11.6% 10 14.9% χ 2 (3) = 4.03; p = 0.26
1–5year 19 27.5% 25 37.3%
5–10year 18 26.1% 9 13.4%
10 year 24 34.8% 23 34.3%
https://doi.org/10.1371/journal.pone.0174531.t001
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consistency (α = .79–.92), and the validity of the Dutch scale is comparable to that of the original
version [39, 40].
Anxiety symptoms were assessed with the Dutch version of the seven anxiety items of the
Hospital Anxiety and Depression Scale (HADS) [41, 42]. Items are scored on a 0–3 Likert scale
and the total score ranges from 0 (no symptoms of anxiety) to 21 (severe symptoms of anxiety).
The internal consistency of the HADS is good (α = .80–.84) as is the test–retest correlation
(r = .89; p< .001).
Sleep-related worries were measured with the Anxiety and Preoccupation about Sleep
Questionnaire (APSQ) [43]. The ASPQ consists of 10 items asking about concerns about sleep,
the consequences of poor sleep and about control of sleep. Items are scored on a scale from 1
(strongly disagree) to 5 (strongly agree) and the total score ranges from 10 to 50 (Jansson-Froj-
mark, Harvey, Lundh, Norell-Clarke, & Linton, 2011). The internal consistency of the APSQ is
excellent (α = .93) and the APSQ correlates significantly with pre-sleep cognitive arousal and
sleep-related beliefs [44].
Sleep-related dysfunctional beliefs were assessed with the Dutch translation of the 16-item
brief Dysfunctional Belief and Attitudes about Sleep scale (DBAS) [45]. Items are scored on a
0–10 Likert scale and the sum of the DBAS score is averaged so that the total score ranges from
0 (no dysfunctional beliefs) to 10 (severe dysfunctional beliefs). The DBAS has good internal
consistency (α = 0.79) and correlates significantly with self-report measures of insomnia sever-
ity, anxiety, and depression.
Sleep diary. We used a Dutch translation of the consensus sleep diary [46]. This diary was
kept throughout the four weeks of the study (28 days). In the diary, participants recorded time
to bed, time they tried to go to sleep, time of final awakening, time out of bed, sleep onset
latency (SOL), wake after sleep onset (WASO), amount of awake time between the final awak-
ening and the time of getting out of bed/ terminal wakefulness (TWAK), number of nightly
awakenings, sleep quality (1 = “very bad” to 5 = “very good”), and use of sleep medication.
From these variables, the time in bed (TIB = final arising time—time to bed), total sleep time
(TST = TIB–SOL–WASO–TWAK), sleep efficiency (SE = [TST/TIB] × 100), and total wake
time (TWT = SOL + WASO + TWAK) were calculated.
Intervention. The ABM training was delivered by means of an adjusted version of the
dot-probe assessment task [47]. When the dot-probe is adapted to training the stimulus-
response contingency is manipulated in order to train participants to shift attention away
from the negative sleep-related stimulus towards the neutral stimulus, thus reducing their
attentional bias towards sleep cues [48]. Thus, in the training condition, the target arrow is
always displayed in the same location previously occupied by the neutral word, thus encourag-
ing selective attention away from the sleep-related negative word. In the placebo condition, the
distribution of the placement of the arrow is 50–50, similarly to the assessment version of the
task. Each training session takes approximately 15 minutes. The training task starts with a
block of eight practice trials followed by two training blocks of 144 trials each, for a total of
2304 training trials across the 8 training sessions.
For the ABM training we used two word sets: set A and set B, both consisting of 24 word
pairs. To assess generalization to new words, different sets were used in the pre- and post-
training assessment. If attentional bias at pre-test was measured with set A, the same set was
used for the ABM placebo or training and set B was used for the post-test attentional bias
assessment. The order of these sets was counterbalanced across participants. Sleep words were
based on the words used in Clarke and colleagues [29] and MacMahon, Broomfield and Espie
[49]. Because we wanted to use 48 word-pairs we also added several worry and sleep-related
words (Please see S1 Table for an English translation of the words).
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The neutral words were matched on the number of times a word appears in Dutch subtitles
since Dutch word frequencies in subtitles is a better predictor than frequencies based on writ-
ten sources [50]. For this purpose, the search engine SUBTLEX -NL was used (http://crr.ugent.
be/subtlex-nl). In addition, the words were matched on the number of syllables.
Procedure
The procedure of this study was registered at www.trialregister.nl (NTR5020) and approved by
the Ethical Review Board of the University of Amsterdam. Recruitment took place in March
2015. After people showed interest in the study they gave informed consent via an online ques-
tionnaire platform (www.qualtrics) where the consent form was stored (this consent procedure
was approved by the Ethical Review Board of the University of Amsterdam). After people gave
their consent they filled in an online screening questionnaire. Through this questionnaire,
inclusion/exclusion criteria were checked and baseline measurements were then administrated
(see Fig 1 for an overview of the participants’ flow). After the baseline assessment, people filled
in a sleep diary for a week for which they received e-mails each day at 5 AM, and if applicable
a reminder at 11 AM. If they completed at least six out of seven days of the diary they were
included in the study and were provided with a link to the online ABM training. After people
logged on to the training online platform they were automatically randomized into the active
or placebo condition, stratified by gender. A computerized randomization algorithm assigned
participants to the condition to which the fewest participants of their gender had been so far
assigned. Both the researchers and the participants were blind to the condition. After randomi-
zation, participants completed the assessment version of the dot-probe task to measure atten-
tional bias before training. Thereafter, the participants started with the first training session. In
total there were eight sessions and each session lasted approximately 15 minutes. These ses-
sions were conducted in the second and third week of the study, from Monday to Thursday.
On these days an invitation e-mail for the training was sent at 7 PM and a reminder at 10 PM.
Participants were asked to carry out the training between 7 PM and 11 PM. In case participants
missed the training session, they could catch up with it during the weekend.
The post-test assessment took place the day after the two-week training was completed.
Regardless of the amount of training sessions completed, the post-test questionnaires were
always administered two weeks after completing the first week of the sleep diary. The follow-
up questionnaires were administered a week after completing the post-test questionnaires. If
people did not fill in the post-test questionnaires, a reminder was sent two days later (and as
a consequence the follow-up was also two days later). The sleep diary was filled in throughout
the four weeks; it started after the baseline questionnaire and stopped together with the follow-
up questionnaire. After completion of the last follow-up questionnaire, participants were
debriefed about the goal of the study and people in the placebo condition got the opportunity
to complete the real ABM training. As a token of gratitude, all participants received an online
or paper version of the self-help treatment materials described in Lancee, Spoormaker, van
Straten, and van den Bout [51].
Statistical analyses
Before running the main analyses, dot-probe task data was pre-processed to limit the influence
of outlying data. Trials with incorrect responses or latencies less than 200ms or greater than
2000ms were removed before computing the attentional bias score. Task split-half reliability
was computed via a bootstrap procedure, by randomly splitting the total amount of trials in
two halves, such that each half had the same number of congruent (i.e., probe at the location of
the sleep-related word) and incongruent trials (i.e., probe at the location of the neutral word).
Attentional bias modification for insomnia
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Next, attentional bias scores were computed for each half and the correlation between these
halves was calculated across participants. The procedure was repeated 100 times and an aver-
age split-half correlation was computed. Test-retest reliability was also computed by correlat-
ing baseline and post-test attentional bias scores.
All analyses were carried out on the intention-to-treat principle with multilevel regression
analyses. Multilevel regression enables the retention of all cases in the analyses (also the ones
that only filled out the pre-test) [52]. In the model, we added ‘time’, ‘condition’, and ‘time x
condition’ as main predictors, with the interaction effect as the main variable of interest.
Before running the multilevel regression models, we checked for possible randomization dif-
ferences at baseline and we found no significant differences between conditions (all p values>
.09). Furthermore, we used t-tests and chi-squares to check whether there were variables asso-
ciated with non-response (i.e. not responding to post-test questionnaires) in either of the con-
dition. In the ABM condition, the following variables were negatively associated with non-
response at post-test and follow-up: PSQI and amount of training sessions completed, suggest-
ing that higher symptom levels and greater engagement in task completion were both associ-
ated with retention in the treatment program. Terminal wakefulness was positively related to
non-response (i.e., higher terminal wakefulness indicated greater non-response rate at post-
test). In the placebo condition, the following variables were negatively associated with non-
response at post-test and follow-up: CESD, HADS-A, and amount of training sessions com-
pleted. Number of awakenings was positively related to non-response (i.e., a higher number of
awakenings was associated with greater non-response rate). If any of these variables correlated
with the dependent variables they were added as a covariate in the multilevel regression
models.
Because we had some missing values at post-test and follow-up, we also used a predictive
mean matching procedure to impute ten separate datasets [53]. The average of these datasets
was used for the missing values. In the tables the means are based on these imputed values. In
addition, we also report results for treatment completers who completed at least six out of the
eight training sessions. For these completers we also imputed the missing values based on mul-
tiple imputation.
Within-group Cohen’s d effect sizes were calculated with: d = Mpre−Mpost/SDpooled, in
which SDpooled =
p
([SDpre2 + SDpost2] / 2). Between-group effect sizes were calculated with:
d = ([Mpre1 –Mpost1]–[Mpre2 –Mpost2]) / SDchange, in which SDchange is the pooled SD of the
pre–post change score. For all the multilevel models we checked whether the residuals met
the assumption of normality. Throughout the study we used an alpha level of .05 (two-sided).
Outlying scores on the main outcome variables were removed if they had a baseline z score
of 3.29 or higher. Three full diaries (baseline and post-test) in the placebo condition were
deleted because participants reported in their baseline diary that they did not sleep for a full
week. Furthermore, we removed the following outliers from the baseline and post-test: one
attentional bias score and one number of awakenings score in the placebo condition; one anxi-
ety, one sleep onset latency, one terminal wakefulness score, and one number of awakenings
score in the experimental condition.
Results
Number of training sessions completed
Of the participants in the ABM-training condition, 58 (86.6%) completed six or more training
sessions and on average they completed 7.10 (SD = 2.05) sessions. Of the participants in the
ABM-placebo condition, 62 (88.6%) completed six or more training sessions and on average
they completed 7.29 session (SD = 1.76), t(135) = .56, p = .58.
Attentional bias modification for insomnia
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Hypothesis 1: Attentional bias prior to training
A paired-sample t-test showed that the average response time on probe on the sleep-word
(M = 720.17, SD = 131.70) was not significantly lower than probe on the neutral word
(M = 720.90, SD = 131.78), t(1, 123) = 0.30, p = .77. This means that, contrary to our first
hypothesis, there was no indication of an attentional bias towards sleep-related word cues in
people with insomnia. Split half reliability of the dot-probe task at baseline was r = -.06, p = .54
and test retest reliability was r = -.09, p = .43.
Hypothesis 2: Efficacy of the training on attentional bias
The multilevel regression analysis showed that there was neither significant time effect nor an
interaction effect (time × condition) on attentional bias scores at post-test. This means that,
contrary to our second hypothesis, the training was not more (nor less) effective in ameliorat-
ing attentional bias than the placebo training. Cohen’s d effect size was equal to .01. In Table 2
means, standard deviations and Cohen’s d of attentional bias scores can be found. See S4 Table
for the multilevel regression analysis. The completers’ sample showed the same pattern as the
imputed sample (S3 Table).
Hypothesis 3: Efficacy of the training on the outcome measures
The multilevel regression analyses showed that there were significant time effects at post-test
for both conditions on the ISI (primary measure), the PSQI, and total sleep time. Significant
time effects were found for the CESD only on the ABM condition and for the HADS-A and
TWAK only for the placebo condition. For the remaining variables no time effects were
observed. Furthermore, no significant interaction effects (time × group) were found on any of
the variables at either the post-test or follow-up. This means that, contrary to our third hypoth-
esis, the training was not more (nor less) effective than the placebo training. Cohen’s d effect
sizes ranged between .00 to .40. In Table 2 means, standard deviations and Cohen’s d for atten-
tional bias, Insomnia Severity Index (ISI), Sleep efficiency, Sleep onset latency, depressive
symptoms (CESD), anxiety symptoms (HADS-A), and worry about sleep (APSQ) can be
found. For the remaining variables, the completers’ sample and the multilevel regression coef-
ficients please see S2–S4 Tables. In the completers’ sample the same pattern of results was
observed as in the imputed sample.
Treatment awareness
Of the 60 participants that filled out the post-test in the placebo condition, seven thought there
was a relationship between the arrow and the words; four of these recognized the correct rela-
tionship. Of the 54 participants in the experimental condition, 12 thought there was a relation-
ship between the words and the arrow; however, none recognized the correct relationship.
Adverse events
There were no adverse events reported in this trial.
Discussion
We investigated whether a multiple-session ABM training could reduce sleep-related atten-
tional bias and sleep complaints in a sample of 137 people with insomnia. In this placebo con-
trolled randomized study we found no indication for the presence of a sleep-related attentional
bias and no evidence that we could change the bias or the sleep complaints. We did observe a
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general reduction in both groups on insomnia symptoms, which is most likely due to non-spe-
cific factors such as keeping a diary and taking part in a research trial.
The absence of a sleep-related attentional bias at baseline is not in line with earlier research
that did evidence an attentional bias toward sleep in individuals with insomnia [16–19], nor is
in line with the models of Harvey [14] and Espie et al. [15] where it is assumed that attentional
bias plays a role in insomnia. However, the findings are in agreement with three other studies
that could not demonstrate this bias using the Stroop task [20–22] and with the first ABM
study that also could not detect an attentional bias using the dot-probe [29]. Our failure to
change attentional bias and sleep problems using ABM could be related to the absence of an
attentional bias at baseline as studies have shown larger ABM effects in individuals with higher
attentional bias at baseline [54, 55]. On the other hand, there have been reports of samples
without an attentional bias at baseline where ABM still reduced attentional bias as well as anxi-
ety symptoms (e.g. [56]).
Table 2. Baseline, Post-test, and Follow-up Scores and Cohen’s d Effect Sizes for the Experimental and Placebo Conditions.
Study variable Condition Baseline Post-test Follow-up Cohen’s d
Mean (SD) Mean
(SD)
Mean
(SD)
Within-group
baseline-post-test
Within-group
baseline-follow-up
Between-group
post-test
Between-group
follow-up
Ins0.00omnia
Severity (ISI)
Experimental 14.39
(3.00)
12.96
(3.88)
12.80
(5.21)
-0.41*** -0.37*** 0.00ns 0.10ns
Placebo 14.73
(3.02)
13.29
(3.48)
13.58
(3.98)
-0.44*** -0.32***
Depressive
symptoms
Experimental 14.63
(6.68)
16.11
(7.93)
14.48
(8.60)
-0.22ns -0.02ns 0.07ns 0.22ns
(CESD) Placebo 15.44
(5.45)
17.42
(7.85)
17.15
(8.81)
-0.29* 0.23ns
Anxiety (HADS) Experimental 6.11 (3.09) 5.55
(3.77)
5.69
(3.94)
-0.16* -0.12** 0.21ns 0.13ns
Placebo 5.73 (3.15) 5.83
(3.15)
5.81
(3.68)
0.02ns 0.01ns
Sleep worry
(APSQ)
Experimental 35.52
(7.40)
31.04
(9.38)
29.89
(10.45)
-0.53*** -0.62*** 0.05ns 0.17ns
Placebo 36.03
(7.15)
32.07
(9.50)
32.03
(10.00)
-0.47*** -0.46***
Sleep onset latency Experimental 41.78
(36.76)
41.38
(32.78)
- -0.01ns - 0.10ns -
(SOL) Placebo 36.98
(28.04)
39.21
(30.42)
-0.10ns
Sleep efficiency
(SE)
Experimental 68.96
(15.66)
70.88
(13.26)
- 0.14ns - 0.09ns -
Placebo 69.10
(14.75)
69.90
(14.41)
0.06ns -
Attentional bias Experimental 3.97
(31.64)
4.77
(21.16)
- 0.03ns - 0.01ns
Placebo -0.99
(25.16)
0.12
(21.28)
-0.05ns
Note. Means, SD’s and d’s are based on the imputed sample. Please see S2–S4 Tables for the remaining variables, the completers’ sample and the
multilevel regression coefficients.
* = p < .05
** = p < .01
*** = p < .001
ns = not significant.
https://doi.org/10.1371/journal.pone.0174531.t002
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At any rate, changing attentional bias is a critical issue since it is the alleged working mecha-
nism of ABM interventions. Furthermore, only when attentional bias is changed, effects on
outcome measures are observed in the field of anxiety [28]. In the current study, we could not
observe any change in attentional bias, which is in line with other research on sleep-related
ABM [29, 30]. The poor psychometric properties of the dot-probe task may provide a possible
valid reason for not observing these changes in bias (which we discuss below). Here, we want
to stress that, if this bias is not changed, it is difficult to draw conclusions on the beneficial
effects of changed attentional bias on outcome measures (i.e., causal relationship) and on the
efficacy of ABM in general.
In contrast to the study of Clarke and colleagues [29], we did not observe significant inter-
action effects (time × group) on any of the outcome variables. Clarke and colleagues [29] did
observe stronger reductions in sleep-related worry and objective sleep onset latency in the
ABM group compared to a placebo condition, but did not find any reduction in insomnia
severity and self-reported sleep onset latency. As we pointed out in the introduction, these
effects could have been a result of a type-I error (i.e., detecting an effect that is not present).
Since our study was more adequately powered, a type-II error is not a probable explanation for
the absence of the effect in our study. Furthermore, our results seem more consistent with the
working mechanism of ABM [57]: no change in attentional bias is associated with no change
in symptoms, whereas observing symptom reductions after no change in attentional bias [29]
is deviating from contemporary models regarding ABM’s mechanism of change.
Another explanation may be that we did not succeed in manipulating the bias, whereas the
studies by Clarke and colleagues [29], and Milkins and colleagues [30] did, albeit failed to
detect it (i.e., a type-II error—not detecting an effect that actually is present). A subsequent log-
ical question is then “what could explain the absence of effect in our study and the observed
effects in these prior studies?” Overall we think that the ABM procedures between the two
studies were highly similar. Therefore, we will now first review the strengths and limitations of
the current study in order to shed more light on the extent that our study should be seen as a
manipulation failure (i.e., not being able to change the attentional bias) or as evidence against
our hypotheses (i.e. ABM training does not lead to improvements in insomnia patients).
In our view, this study had several strengths. First, as we mentioned, the study was ade-
quately powered to find an average effect size difference (n = 137 in our study, versus n = 36 in
[29]); therefore, we are confident that the null findings in this study were not due to a lack of
power. Second, we used a randomized placebo controlled double-blind design and we followed
CONSORT guidelines [58]. Furthermore, we included people who suffered from insomnia
based on DSM-5 criteria, which is more ecologically valid than testing students or good sleep-
ers. In addition, we used a naturalistic design by deploying the ABM training online so people
could do the training at home (but did not do so with a smartphone app as Clarke and col-
leagues [29]). However, the naturalistic design is also a limitation of the study since this meant
that we had no optimal control over the training (e.g., time of administration, computer screen
sizes, etc.). This may be of especial importance for the online measurement of the dot-probe.
The dot-probe is a timed task that may be susceptible to variances in internet speed and/or
precision of computer timer system (although several studies have reported similar effects of
studies delivered at home compared to those delivered in the lab [59–61]). For instance,
Carlbring and colleagues [62] found that a previously effective offline study on social anxiety
was not successfully translated to an online format.
There were also some (other) limitations to this study. The most important limitation
regards the psychometric properties of the attentional bias measurement task (dot-probe). As
we mentioned above, we detected neither attentional bias at baseline nor any change of atten-
tional bias. Recently it was shown that the dot-probe task lacks reliability [63, 64]. For instance,
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Waechter and colleagues [64] found Cronbach’s alpha’s for attentional bias scores in the range
of .03–.25. The same pattern was found in our sample with a split-half reliability of r = -.06.
This means that the (change in) attentional bias may have been present in our sample, but the
dot-probe may have failed to detect it. This poses a serious problem since now we cannot be
certain whether we did not succeed in changing the attentional bias or we could not detect this
change. Future studies should employ a more reliable measure of attentional bias (for instance
a visual search task—[65]) or should consider using self-reported measures of sleep-related
attention bias (e.g. [66]). However, the dot-probe is seen as a standard task to assess attentional
bias and Harris and colleagues [23] concluded that the dot-probe (together with the flicker
and Posner) appeared one of the most sensitive for group effects.
Apart from this point, there were other limitations to this study. One concerns the timing
of the ABM task delivery. In the present study participants were instructed to complete the
training between 7 PM and 11 PM. This was designed to target the delivery of the ABM in the
lead-up to sleep when biased attention to threat may begin to be problematic, while not requir-
ing participants to complete this task at a time that could interfere with the process of falling
asleep. This does however, represent a point of difference from the two earlier studies [29, 30]
where the participants were instructed to complete the task immediately before going to bed.
As Milkins and colleagues [30] argued, it may be that ABM is most beneficial if it is delivered
immediately prior to sleep when the biased attention may be most problematic. Another
option is that an ABM training so close to bedtime may lead to increase arousal. This would
mean that such a training could better be offered during the day. Second, we based our words
on the words used by Clarke and colleagues [29] and these were based on the three-factors of
Wicklow and Espie [67]. The study may have been more matched to the target problem if we
used only sleep-related words such as those used in Barclay and Ellis [21]. Third, in accordance
to the Clark study [29] we used words as stimuli; however, pictorial stimuli may also have been
an option for insomnia-related attentional bias and future studies may need to consider other
tasks such as a modified Posner. Fourth, we deployed the ABM training online for computers
and not on smartphones as Clarke and colleagues [29] did. Other limitations include the self-
selected sample and that, due to the online design of the study, we did not have a formal clini-
cal diagnosis of insomnia (although we used DSM-5 guidelines and the ISI 10 cutoff).
When weighing these strengths and limitations, it is difficult to give a definite answer to the
question whether our study should be seen as a failed manipulation of attentional bias or as
evidence against the hypotheses. Regarding the failed manipulation, we think the most serious
limitation of our study (and indeed many past research) is the unreliable dot-probe task. We
believe it is critical to replicate our study with a measure capable of reliably assessing attentions
bias. If such study, again, does not observe (changes in) attentional bias, it can be concluded
that ABM trainings are not (yet) able to change sleep-related attentional bias. If on the other
hand, these changes on attentional bias are observed, but do not lead to symptom changes, this
would have strong implications for the theoretical and clinical role of attentional bias (train-
ing) in insomnia research. Specifically, such a finding would suggest that attentional bias for
sleep-related negative information may be a cognitive correlate of insomnia, but is not causally
related to disturbed sleep. As long as no such study with adequate measurements has been
reported, we think that no firm conclusions can be drawn on the role of (changing) attentional
bias in insomnia complaints. Therefore, the results of the current study clearly provide no evi-
dence for the clinical efficacy of ABM for insomnia and suggest caution in interpreting the
potential applied benefits of such an intervention approach on the basis of other recent find-
ings [29, 30]. Given the outcome of the present study, the possibility that these past results
could potentially represent a Type-I error will remain until it can be shown that such effects
can be replicated.
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